Synthesis and activity of tryptophan sulfonamide derivatives as novel non-hydroxamate TNF-alpha converting enzyme (TACE) inhibitors.
Park, K., Gopalsamy, A., Aplasca, A., Ellingboe, J.W., Xu, W., Zhang, Y., Levin, J.I.(2009) Bioorg Med Chem 17: 3857-3865
- PubMed: 19410464 
- DOI: https://doi.org/10.1016/j.bmc.2009.04.033
- Primary Citation of Related Structures:  
3G42 - PubMed Abstract: 
A novel series of non-hydroxamate tryptophan sulfonamide derivatives containing a butynyloxy P1' moiety was identified as inhibitors of TNF-alpha converting enzyme (TACE). The structure-activity relationship of the series was examined via substitution on the tryptophan indole ring. Of the compounds investigated, 2-(4-(but-2-ynyloxy)phenylsulfonamido)-3-(1-(4-methoxybenzyl)-1H-indol-3-yl)propanoic acid (12p) has the best in vitro potency against isolated TACE enzyme with an IC(50) of 80 nM. Compound 12p also shows good selectivity over MMP-1, -13, -14.
Organizational Affiliation: 
Chemical Sciences, Wyeth Research, 401 N. Middletown Road, Pearl River, NY 10965, USA. ParkK3@wyeth.com